DKS Co. Ltd.(4461) News

Notice Concerning the Implementation of the Shareholder Benefit Program

Notice Concerning the Nomination of a Candidate for Outside Director

Notice Concerning the Change of Title of the Representative Director

Notice Concerning Organizational and Personnel Changes

Consolidated Financial Results for the Nine Months Ended December 31, 2025

(Corrections)Consolidated Financial Results for the Six Months Ended September 30, 2025

Notice Revision of Consolidated Financial Forecast and Dividend Forecast for the Fiscal Year Ending March 31, 2026

DKS, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 20%, Raises Record High Profit Forecast, Dividend Revised Upward by 10 Yen

DKS OBTAINS HALAL CERTIFICATION FOR SUCROSE ESTERS　to strengthen sales in Muslim markets

Notice Concerning Payment Completion for the Disposal of Treasury Stock under the Employee Shareholding Association-Restricted Stock Incentive Plan

DKS, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 16%, Raises Record High Profit Forecast, Dividend Revised Upward by 20 Yen

Notice Concerning Results of Joint Research with D. Western Therapeutics Institute, Inc.

Notice Concerning the Commencement of Joint Research with Kyoto University

Notice Revision of Consolidated Financial Forecast and Dividend Forecast for the Fiscal Year Ending March 31, 2026

Consolidated Financial Results for the Six Months Ended September 30, 2025

Determination of Disposal Price and Selling Price, etc.

Notice Concerning Disposal of Treasury Stock under the Employee Shareholding Association-Restricted Stock Incentive Plan

Notice Disposal of Treasury Stock and Secondary Offering of Shares

Consolidated Financial Results for the Three Months Ended June 30, 2025(Completion of the interim review by certified public accountants,etc)

DKS, Ordinary Profit Forecast for First Half Revised Upward by 29%, Raises Record High Profit Forecast, Full Year also Increased